Plante Moran Financial Advisors’s ResMed RMD Stock Holding History

Plante Moran Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Buy	+10	New	+$2.07K	﹤0.01%	746
2023 Q1	–	Sell	-54	Closed	-$11.2K	–	885
2022 Q4	$11.2K	Buy	+54	New	+$11.9K	﹤0.01%	562
2022 Q1	–	Sell	-35	Closed	-$9K	–	969
2021 Q4	$9K	Buy	+35	New	+$9.08K	﹤0.01%	703
2020 Q4	–	Sell	-15	Closed	-$3K	–	972
2020 Q3	$3K	Buy	+15	New	+$2.77K	﹤0.01%	751
2018 Q2	–	Sell	-129	Closed	-$13K	–	944
2018 Q1	$13K	Hold	129	–	–	0.01%	569
2017 Q4	$11K	Buy	+129	New	+$10.7K	0.01%	582

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Plante Moran Financial Advisors's RMD Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in ResMed (RMD) in Q2 2026: 10 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #746 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in RMD as recently as Q4 2022.

Plante Moran Financial Advisors first reported a position in RMD in Q4 2017 and has held it in 6 quarters since. The position peaked at $13K in Q1 2018. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Plante Moran Financial Advisors held 10 shares of ResMed worth $1.95K as of Q2 2026.
ResMed was a new Plante Moran Financial Advisors position in Q2 2026.
ResMed made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #746 holding.
Plante Moran Financial Advisors first reported a position in ResMed in Q4 2017 and has held it in 6 quarters since.
Plante Moran Financial Advisors's ResMed position peaked at $13K in Q1 2018.
885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.